Literature DB >> 21316328

Minimization of radiation exposure due to computed tomography in inflammatory bowel disease.

S B O'Neill1, O J O'Connor, S R McWilliams, F Shanahan, M M Maher.   

Abstract

Exposure to ionising radiation as a result of diagnostic imaging is increasing among patients with inflammatory bowel disease (IBD), primarily due to the more widespread use of computed tomography (CT). The potentially harmful effects of ionising radiation are a major cause for concern and radiologists, technologists and referring physicians who have a responsibility to the patient to ensure judicious use of those imaging modalities which result in exposure to ionising radiation and, when imaging is necessary, to ensure that a diagnostic quality imaging examination is acquired with lowest possible radiation exposure. This can be achieved by limiting the use of those imaging studies which involve ionising radiation to clinical situations where they are likely to change management, by implementing advances in low-dose CT technology, and, where feasible, by using alternative imaging modalities, such as ultrasonography or magnetic resonance imaging, which avoid radiation exposure.
Copyright © 2011. Published by Elsevier Masson SAS.

Entities:  

Mesh:

Year:  2011        PMID: 21316328     DOI: 10.1016/j.clinre.2010.11.007

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN: 2210-7401            Impact factor:   2.947


  2 in total

1.  Magnetic resonance imaging of the chest in the evaluation of cancer patients: state of the art.

Authors:  Marcos Duarte Guimaraes; Bruno Hochhegger; Marcel Koenigkam Santos; Pablo Rydz Pinheiro Santana; Arthur Soares Sousa; Luciana Soares Souza; Edson Marchiori
Journal:  Radiol Bras       Date:  2015 Jan-Feb

2.  Radiation Exposure in Patients with Inflammatory Bowel Disease: a Fourteen-Year Review at a Tertiary Care Centre in Malaysia

Authors:  Jeevinesh Naidu; Zhiqin Wong; Shanthi Palaniappan; Chai Soon Ngiu; Nur Yazmin Yaacob; Hamzaini Abdul Hamid; Marjanu Hikmah Elias; Norfilza Mohamad Mokhtar; Raja Affendi Raja Ali
Journal:  Asian Pac J Cancer Prev       Date:  2017-04-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.